Oxytocin Protects Nigrostriatal Dopamine Signal via Activating GABAergic Circuit in the MPTP‐Induced Parkinson's Disease Model
Advanced Science · 2024-09 · 11 (36)
DOI: 10.1002/advs.202310244 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 05.08.2024. Verfasst von Yurong Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Stomatological Hospital & School of Stomatology, The State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science, a…. Hauptthemen laut MEDLINE: Oxytocin, Substantia Nigra, Disease Models, Animal, Dopamine. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Lingang Laboratory, Shanghai Municipal Science and Technology Major Project.
Abstract (Originalsprache)
The most pronounced neuropathological feature of Parkinson's disease (PD) is the loss of dopamine (DA) neurons in the substantia nigra compacta (SNc), which depletes striatal DA. Hypothalamic oxytocin is found to be reduced in PD patients and closely interacts with the DA system, but the role of oxytocin in PD remains unclear. Here, the disturbances of endogenous oxytocin level and the substantia nigra (SN) oxytocin receptor expression in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐induced PD mouse model is observed, correlated with the striatal tyrosine hydroxylase (TH) expression reduction. Killing/silencing hypothalamic oxytocin neurons aggravates the vulnerability of nigrostriatal DA signal to MPTP, whereas elevating oxytocin level by intranasal delivery or microinjecting into the SN promotes the resistance. In addition, knocking out SN oxytocin receptors induces the time‐dependent reductions of SNc DA neurons, striatal TH expression, and striatal DA level by increasing neuronal excitotoxicity. These results further uncover that oxytocin dampens the excitatory synaptic inputs onto DA neurons via activating oxytocin receptor‐expressed SN GABA neurons, which target GABA(B) receptors expressed in SNc DA neuron‐projecting glutamatergic axons, to reduce excitotoxicity. Thus, besides the well‐known prosocial effect, oxytocin acts as a key endogenous factor in protecting the nigrostriatal DA system.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Stomatological Hospital & School of Stomatology, The State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science, and the Institutes of Brain Science, Fudan University, Shanghai, 200032…
ORCID-Profile: Lei Xiao
Förderung
- National Natural Science Foundation of China
- Lingang Laboratory
- Shanghai Municipal Science and Technology Major Project
- Shanghai Center for Brain Science and Brain-Inspired Technology
Zitieren
APA
Wang, Y., Xu, H., Chen, S., Chen, J., Zheng, Q., Ma, Y., Zhao, X., Shi, Y., & Xiao, L. (2024). Oxytocin Protects Nigrostriatal Dopamine Signal via Activating GABAergic Circuit in the MPTP‐Induced Parkinson's Disease Model. Advanced Science, 11(36). https://doi.org/10.1002/advs.202310244
Vancouver
Wang Y, Xu H, Chen S, Chen J, Zheng Q, Ma Y, et al. Oxytocin Protects Nigrostriatal Dopamine Signal via Activating GABAergic Circuit in the MPTP‐Induced Parkinson's Disease Model. Advanced Science. 2024;11(36). doi:10.1002/advs.202310244
BibTeX
@article{Wang2024,
author = {Wang, Yurong and Xu, Hao and Chen, Saiyong and Chen, Junhao and Zheng, Qimeng and Ma, Yuanyuan and Zhao, Xinru and Shi, Ying and Xiao, Lei},
title = {Oxytocin Protects Nigrostriatal Dopamine Signal via Activating GABAergic Circuit in the MPTP‐Induced Parkinson's Disease Model},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {36},
doi = {10.1002/advs.202310244}
}
EUVIMED